The Journal of Heart and Lung Transplantation
Volume 29, Issue 7 , Pages 728-730 , July 2010

In praise of ventricular assist devices—mechanical bridge to virtual crossmatch for the sensitized patient

  • Heather Ross, MHSc, MD

      Affiliations

    • Corresponding Author InformationReprint requests: Heather Ross, MD, Toronto General Hospital, NCSB 11C-1203, University Health Network, 585 University Avenue, Toronto, ON M5G 2N2, Canada.
    • ,
  • Kathryn Tinckam, MHSc, MD
    • ,
  • Vivek Rao, MD, PhD
    • ,
  • Lori J. West, MD, DPhil

References 

  1. Nwakanma LU, Williams JA, Weiss ES, et al. Influence of pretransplant panel-reactive antibody on outcomes in 8,160 heart transplant recipients in recent era. Ann Thorac Surg. 2007;84:1556–1563
  2. Kfoury AG, Stehlik J, Renlund DG, et al. Impact of repetitive episodes of antibody-mediated or cellular rejection on cardiovascular mortality in cardiac transplant recipients: defining rejection patterns. J Heart Lung Transplant. 2006;25:1277–1282
  3. Morales-Buenrostro LE, Castro R, Terasaki PI. A single human leukocyte antigen–antibody test after heart or lung transplantation is predictive of survival. Transplantation. 2008;85:478–481
  4. Tambur AR, Pamboukian SV, Costanzo MR, et al. The presence of HLA-directed antibodies after heart transplantation is associated with poor allograft outcome. Transplantation. 2005;80:1019–1025
  5. Kfoury AG, Renlund DG, Snow GL, et al. A clinical correlation study of severity of antibody-mediated rejection and cardiovascular mortality in heart transplantation. J Heart Lung Transplant. 2009;28:51–57
  6. Smith JD, Hamour IM, Banner NR, et al. C4d fixing, luminex binding antibodies—a new tool for prediction of graft failure after heart transplantation. Am J Transplant. 2007;7:2809–2815
  7. Kobashigawa J, Mehra M, West L, et al. Consensus conference participants. J Heart Lung Transplant. 2009;28:213–225
  8. Taylor DO, Yowell RL, Kfoury AG, et al. Allograft coronary artery disease: clinical correlation with circulating anti-HLA antibodies and the immunohistopathologic pattern of vascular rejection. J Heart Lung Transplant. 2000;19:518–521
  9. Wu GW, Kobashigawa JA, Fishbein MC, et al. Asymptomatic antibody-mediated rejection after heart transplantation predicts poor outcomes. J Heart Lung Transplant. 2009;28:417–422
  10. Stastny P, Lavingia B, Fixler DE, et al. Antibodies against donor human leukocyte antigens and the outcome of cardiac allografts in adults and children. Transplantation. 2007;84:738–745
  11. Bayliss J, Bailey M, Leet A, et al. Late onset antibody-mediated rejection and endothelial localization of vascular endothelial growth factor are associated with development of cardiac allograft vasculopathy. Transplantation. 2008;86:991–997
  12. 2008 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1998-2007. U.S. Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD. http://optn.transplant.hrsa.gov/ar2008/ (accessed March 18, 2010).
  13. Noreen HJ, McKinley DM, Gillingham KJ, et al. Positive remote crossmatch: impact on short-term and long-term outcome in cadaver renal transplantation. Transplantation. 2003;75:501–505
  14. Speiser DE, Jeannet M. Renal transplantation to sensitized patients: decreased graft survival probability associated with a positive historical crossmatch. Transplant Immunol. 1995;3:330–334
  15. Bryan CF, Shield CF, Warady BA, et al. Influence of an historically positive crossmatch on cadaveric renal transplantation. Transplant Proc. 1999;31:225–227
  16. Segev DL, Gentry SE, Warren DS, et al. Kidney paired donation and optimizing the use of live donor organs. JAMA. 2005;293:1883–1890
  17. Pagani FD, Miller LW, Russell SD, et al. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol. 2009;54:312–321
  18. Slaughter MS, Rogers JG, Milano CA, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361:2241–2251
  19. Kirklin JK, Naftel DC, Kormos RL, et al. Second INTERMACS annual report: more than 1,000 primary left ventricular assist device implants. J Heart Lung Transplant. 2010;29:1–10
  20. Drakos SG, Kfoury AG, Kotter JR, et al. Prior human leukocyte antigen–allosensitization and left ventricular assist device type affect degree of post-implantation human leukocyte antigen-allosensitization. J Heart Lung Transplant. 2009;28:838–842

PII: S1053-2498(10)00078-1

doi: 10.1016/j.healun.2010.02.006

The Journal of Heart and Lung Transplantation
Volume 29, Issue 7 , Pages 728-730 , July 2010

Article Tools

* Image Usage & Resolution